ArticlePloS one2013
HPV prevalence among women from Appalachia: results from the CARE project.
Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT02113514 (Community Awareness, Resources and Education), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Community Awareness, Resources and Education (CARE I): Project 3
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.Human vaccines & immunotherapeutics · 2022Pooled it
- Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016Trial
- STEPS (Study To Examine Parent, Patient/Dental Provider Systems) to prevent human papillomavirus (HPV)-related cancers: A formative assessment of HPV educational engagement of the dental practice.Preventive oncology & epidemiology · 2025Article
- Serum profiling of the antibody response to HPV in women with or without abnormal cervical cytology undergoing cervical cancer screening.Frontiers in immunology · 2025Article
- The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study.Gynecology and pelvic medicine · 2020Article
- A Multi-level Model to Understand Cervical Cancer Disparities in Appalachia.Cancer prevention research (Philadelphia, Pa.) · 2020Article
- Latent Profiles of Health and Reproductive Risk and Protective Factors among Women in Appalachia.Journal of social work practice in the addictions · 2020Article
- Inherited alterations of TGF beta signaling components in Appalachian cervical cancers.Cancer causes & control : CCC · 2019Article
- Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff.Journal of cancer education : the official journal of the American Association for Cancer Education · 2018Article
- Disparity in rates of HPV infection and cervical cancer in underserved US populations.Frontiers in bioscience (Scholar edition) · 2017Review
- Prioritizing US Cervical Cancer Prevention With Results From a Geospatial Model.Journal of global oncology · 2016Article
- Review: Increasing Awareness and Education on Health Disparities for Health Care Providers.Ethnicity & disease · 2016Review
- Cervical cancer worry and screening among appalachian women.The journal of primary prevention · 2015Article
- Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2015Article
- Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact.Online journal of public health informatics · 2014Article
- Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.Women & healthArticle
Corrections and comments
- Erratum issued
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundCervical cancer incidence and mortality rates are high among women from Appalachia, yet data do not exist on human papillomavirus (HPV) prevalence among these women. We examined the prevalence of genital HPV among Appalachian women and identified correlates of HPV detection.
methodsWe report data from a case-control study conducted between January 2006 and December 2008 as part of the Community Awareness, Resources, and Education (CARE) Project. We examined HPV prevalence among 1116 women (278 women with abnormal Pap tests at study entry [cases], 838 women with normal Pap tests [controls]) from Appalachian Ohio. Analyses used multivariable logistic regression to identify correlates of HPV detection.
resultsThe prevalence of HPV was 43.1% for any HPV type, 33.5% for high-risk HPV types, 23.4% for low-risk HPV types, and 12.5% for vaccine-preventable HPV types. Detection of any HPV type was more common among women who were ages 18-26 (OR = 2.09, 95% CI: 1.26-3.50), current smokers (OR = 1.86, 95% CI: 1.26-2.73), had at least five male sexual partners during their lifetime (OR = 2.28, 95% CI: 1.56-3.33), or had multiple male sexual partners during the last year (OR = 1.98, 95% CI: 1.25-3.14). Similar correlates were identified for detection of a high-risk HPV type.
conclusionsHPV was prevalent among Appalachian women, with many women having a high-risk HPV type detected. Results may help explain the high cervical cancer rates observed among Appalachian women and can help inform future cervical cancer prevention efforts in this geographic region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.